Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
REVENUES $ 1,348 $ 1,422 $ 6,297 $ 5,995
COST OF REVENUES 813 896 3,258 3,002
GROSS PROFIT 535 526 3,039 2,993
OPERATING EXPENSES:        
Research and development expenses, net 723 552 2,049 1,818
Sales and marketing expenses, net 790 627 2,357 1,576
General and administrative expenses, net 1,028 255 2,730 906
TOTAL OPERATING EXPENSES 2,541 1,434 7,136 4,300
OPERATING LOSS (2,006) (908) (4,097) (1,307)
Financial expenses, net (201) (279) (4,403) (592)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (2,207) $ (1,187) $ (8,500) $ (1,899)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.13) $ (0.58) $ (0.88) $ (0.93)
Weighted average number of common stock used in computing net loss per share – basic (in Shares) 17,317,532 2,049,433 9,687,205 2,048,241